Your browser doesn't support javascript.
loading
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.
Kallander, Lara S; Washburn, David; Hilfiker, Mark A; Eidam, Hilary Schenck; Lawhorn, Brian G; Prendergast, Joanne; Fox, Ryan; Dowdell, Sarah; Manns, Sharada; Hoang, Tram; Zhao, Steve; Ye, Guosen; Hammond, Marlys; Holt, Dennis A; Roethke, Theresa; Hong, Xuan; Reid, Robert A; Gampe, Robert; Zhang, Hong; Diaz, Elsie; Rendina, Alan R; Quinn, Amy M; Willette, Bob.
Afiliação
  • Kallander LS; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Washburn D; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Hilfiker MA; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Eidam HS; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Lawhorn BG; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Prendergast J; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Fox R; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Dowdell S; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Manns S; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Hoang T; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Zhao S; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Ye G; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Hammond M; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Holt DA; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Roethke T; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Hong X; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Reid RA; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Gampe R; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Zhang H; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Diaz E; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Rendina AR; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Quinn AM; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
  • Willette B; Heart Failure Discovery Performance Unit, Metabolic Pathways and Cardiovascular Therapeutic Area, and Platform Technology and Sciences, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, United States.
ACS Med Chem Lett ; 9(7): 736-740, 2018 Jul 12.
Article em En | MEDLINE | ID: mdl-30034610

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article